Related Experiment Video
Updated: May 12, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in
1Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan. tozaki@chiba-cc.jp
Runt-related transcription factor 2 (RUNX2) suppresses p53
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Runt-related transcription factor 2 (RUNX2) is primarily known for its role in osteoblast differentiation.
- The function of RUNX2 in DNA damage response pathways, particularly its interaction with p53, is not well understood.
Purpose of the Study:
- To investigate the novel role of RUNX2 as a regulator of p53 activity in response to DNA damage.
- To elucidate the molecular mechanisms underlying RUNX2's interaction with p53 and its impact on p53 target gene expression.
Main Methods:
- Utilized human osteosarcoma (U2OS) and lung carcinoma (H1299) cell lines.
- Employed adriamycin (ADR) to induce DNA damage.
- Performed indirect immunostaining, co-immunoprecipitation, chromatin immunoprecipitation (ChIP) assays, gene expression analysis (mRNA and protein levels), and knockdown/overexpression studies.
- Investigated the role of histone deacetylase 6 (HDAC6) and its inhibitor tubacin.
Main Results:
- RUNX2 and p53 protein and mRNA levels were induced upon ADR treatment in U2OS cells.
- RUNX2 formed a complex with p53 in the nucleus and was recruited to p53 target promoters.
- Forced expression of RUNX2 downregulated p53 target genes, while RUNX2 knockdown enhanced apoptosis and p53 target gene expression.
- RUNX2's effect on p53 target genes was p53-dependent.
- The RUNX2/p53 complex recruited HDAC6, and HDAC6's deacetylase activity was necessary for RUNX2-mediated downregulation of p53 target genes.
Conclusions:
- RUNX2 acts as a negative regulator of p53 in response to DNA damage.
- RUNX2 inhibits the transcriptional and pro-apoptotic activity of p53 through collaboration with HDAC6.
- This RUNX2-HDAC6-p53 axis presents a potential therapeutic target for cancer treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:43A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
Published on: August 31, 2013
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...